Filing Details

Accession Number:
0001209191-20-019005
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-03-13 17:41:46
Reporting Period:
2020-03-12
Accepted Time:
2020-03-13 17:41:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1001233 Sangamo Therapeutics Inc SGMO Biological Products, (No Disgnostic Substances) (2836) 680359556
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1331852 S Joseph Zakrzewski C/o Sangamo Therapeautics, Inc.
7000 Marina Blvd
Brisbane CA 94005
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-03-12 15,000 $6.31 20,000 No 4 P Direct
Common Stock Acquisiton 2020-03-13 5,000 $5.67 25,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. Includes 2,500 shares of common stock subject to restricted stock units ("RSUs") granted on June 10, 2019. The RSUs will fully vest on the earlier of (x) June 10, 2020 (the first anniversary of the date of grant) or (y) the day prior to Issuer's 2020 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such dates.